- Poster presentation
- Open Access
PReS-FINAL-1011: Can repeated T cell receptor stimulation lead to epigenetic reprogramming of the treg-specific demethylated region in human conventional T cells?
© Wu et al.; licensee BioMed Central Ltd. 2013
- Published: 5 December 2013
- Treg Cell
- FoxP3 Expression
- Bisulfite Sequencing
- Epigenetic Reprogram
- Cytokine Combination
Regulatory T (Treg) cells, vital to prevent autoimmune disease, can be identified by their expression of the forkhead box P3 (FoxP3) transcription factor. Human conventional T (Tconv) cells stimulated via the T cell receptor (TCR) can also express FoxP3. Although this can confer some intrinsic regulatory effects, controversy exists over whether FoxP3 expression alone gives rise to the Treg cell phenotype. Treg-specific demethylated region (TSDR) demethylation is thought to be a reliable marker of commitment to the Treg cell lineage. In most human studies, analysis of TSDR methylation status has been performed on bulk populations, where only a subpopulation of cells express FoxP3. However, TSDR demethylation may occur selectively in cells expressing the highest levels of FoxP3 protein. Previously, investigation of epigenetic modifications in FoxP3+ human Tconv cells has been hampered by the inability to separate cells on the basis of FoxP3 expression. Recently, however, a protocol has been published detailing a method for DNA extraction from cells that have been fixed and stained for FoxP3, permitting more informative phenotyping of TSDR methylation status.
To examine the kinetics and stability of FoxP3 expression in human Tconv cells undergoing repeated TCR stimulation; in addition to analyze the TSDR methylation status on cells separated based on FoxP3 expression.
Cells were separated into CD4+CD25hiCD127lo (Treg) and CD4+CD25-CD127hi (Tconv) populations and cultured for 3 weeks with anti-CD3, anti-CD28, cytokine combinations and, in some experiments, demethylating agent 5-azacytidine (5-azaC). At regular intervals, cells were analyzed for expression of Treg cell markers. On days 7 and 16, Tconv cells were sorted into CD4+CD25+FoxP3+ and CD4+CD25+FoxP3- populations for DNA extraction and bisulfite sequencing to analyze TSDR methylation status.
Activation-induced FoxP3 expression in Tconv cells was augmented by interleukin-2 (IL-2), but was unstable. TSDR became partially demethylated in the day 7 FoxP3+ population in one of two donors. 5-azaC stabilized FoxP3 protein expression and this was associated with a small increase in overall TSDR demethylation.
FoxP3 protein expression alone may not be an adequate marker of Treg cells in states of chronic stimulation, where a notable proportion of FoxP3-expressing cells may be recently activated Tconv cells. TSDR demethylation may be a more specific marker of commitment to the Treg cell lineage. However, preliminary results suggest a small subpopulation of FoxP3-expressing Tconv cells may demethylate at the TSDR in response to TCR stimulation, warranting further investigation. This work may contribute towards understanding how induced Treg cells could be stably generated in vitro, with potential applications in adoptive transfer therapies for the treatment of autoimmune disease.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.